Skip to content
MG
Public company · Nasdaq: MMED

Updated:

MiniMed Group, Inc.

MiniMed develops, manufactures and markets medical technology for diabetes management, including integrated treatment systems. Its annual report notes a...

Overview

MiniMed develops, manufactures and markets medical technology for diabetes management, including integrated treatment systems. Its annual report notes a limited history of operating as a standalone public company. Its MMED shares are listed on Nasdaq. Its reported principal executive office is in Northridge, CA, United States. For the fiscal year ended 2026-04-24, the originally reported results include revenue of USD 3,102,000,000; net income of USD -333,000,000; operating cash flow of USD -197,000,000. At that year-end, its balance sheet reports total assets of USD 4,630,000,000 and cash and cash equivalents of USD 298,000,000.

Company overview

Legal name
MiniMed Group, Inc.
Former names in filing history
MDT Sub Holdings, Inc. (2025-05-30 to 2025-05-30)
Classification
Public company
Industry (SIC)
3841 — Surgical & Medical Instruments & Apparatus
Headquarters
Northridge, CA, United States
Incorporated in
DE
Fiscal year end
December 31
Tickers
Nasdaq: MMED, Nasdaq: MMEDV
SEC CIK
0002062583

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2026USD$3.1B-$333.0M$4.6B$298.0M-$197.0M

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
S-4—S-4
10-Q10-Q
8-K8-K
DEF 14ADEF 14A
8-KFORM 8-K
10-K10-K
8-KFORM 8-K
8-K8-K
8-KFORM 8-K
8-KFORM 8-K
10-Q10-Q

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research MiniMed Group, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More SEC-Reporting Public Company profiles

MiniMed Group, Inc. (Nasdaq: MMED) — company profile | Altss